Genetic etiology and Diagnostic strategies for Duchenne and Becker Muscular Dystrophy: A 2012 update

1. Darras BT, Korf RB, Urion DK. Dystrophinopathies. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. Gene reviews. 8th ed. University of Washington. 2008. Bookshelf ID: NBK1119 PMID: 20301298
2. Dooley J, Gordon KE, Dodds L, MacSween J. Duchenne muscular dystrophy: a 30-year population-based incidence study. Clin Pediatr (Phila) 2010 Mar;49(2):177-9.
3. Centers for Disease Control and Prevention (CDC). Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years - four states, 2007. MMWR Morb Mortal Wkly Rep 2009;58:1119-22.
4. Talkop UA, Khare T, Napa A, Talvik I, SootA, Piirsoo A, Sander V, Talvik T. A descriptive epidemiological study of DMD in childhood in Estonia. Eur J Paediatr Neural 2003;7:221-6
5. Kanamari M. Institute of public Health Genetic epidemiology of DMD in Japan. Hokkaida Igaku Zasshi
1988;63:85-8
6. Roddie A, Bundey S. Racial distribution of Duchenne muscular dystrophy in the west midlands region of
Britain. J. Med. Genet 1992;29:555-557
7. Saito K, Ikeya K, Kondo E, Komine S, Komine M, Osawa M, Aikawa E, Fukuyama Y. Somatic mosaicism for a DMD gene deletion. Am J Med Genet 1995 Mar 13;56(1):80-6.
8. Mukherjee M, Chaturvedi LS, Srivastava S, Mittal RD and Mittal B. De novo mutations in sporadic deletional Duchenne muscular dystrophy (DMD) cases. Experimental and Molecular Medicine 2003
April;35(2):113-117
9. Chamberlain JS, Gibbs RA, Ranier JE, Nguyen PN, Caskey CT. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res 1988;16:11141-56
10. Beggs AH, Hoffman EP, Snyder LR, Arahata K, Specht L, Shapiro F et al. Exploring the Molecular Basis for Variability among Patients with Becker Muscular Dystrophy: Dystrophin Gene and Protein Studies. Am. J. Hum. Genet 1991;49:54-67
11. Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettecken T, et al. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet 1989 Oct;45(4):498-506.
12. Aartsma-Rus A, van Deutekom, Fokkema IF, van Ommen GJ, Den Dunnen JT. Entries in the Leiden Duchenne Muscular database: An overview of mutations types and paradoxical cases that comfirm the reading frame rule. Muscle Nerve 2006;34:135-44
13. Prior TW and Bridgeman SJ. Experience and Strategy for the Molecular Testing of DMD. Journal of molecular Diagnosis 2005;7
14. Lindlöf M, Kiuru A, Kaariainen H, Kalimo H, Lang H, Pihko H, et al. Gene deletions in X-linked muscular dystrophy. Am J Hum Genet 1989;44:496-503
www.ijbamr.com
365
Indian Journal of Basic & Applied Medical Research; December 2012: Issue-5, Vol.-2, P. 357-369
15. van Essen AJ, Abbs S, Baiget M, Bakker E, Boileau C, van Broeckhoven C, et al. Parental origin and germline mosaicism of deletions and duplications of the dystrophin gene: a European study. Hum Genet.
1992; 88:249-57
16. Baumbach LL, Chamberlain JS, Ward PA, Farwell NJ, Caskey CT. Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology 1989 Apr;39(4):465-74.
17. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, and Kunkel LM. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987;50:509-517.
18. Cutiongco EM, Padilla CD, Takenaka K, Yamasaki Y, Matsuo M, Nishio H. More deletions in the 5' region than in the central region of the dystrophin gene were identified among Filipino Duchenne and Becker muscular dystrophy patients. Am J Med Genet 1995 Nov 6;59(2):266-7.
19. Passos-Bueno MR, Bakker E, Kneppers AL, Takata RI, Rapaport D, den Dunnen JT, et al. Different mosaicism frequencies for proximal and distal Duchenne muscular dystrophy (DMD) mutations indicate difference in etiology and recurrence risk. Am J Hum Genet 1992;51(5): 1150-5.
20. Nobile C, Marchi J, Nigro V, Roberts RG, Danieli GA. Exon-intron organization of the human dystrophin gene. Genomics 1997;45:421-4.
21. Sura T, Eu-ahsunthornwattana J, Pingsuthiwong S, Busabaratana M. Sensitivity and frequencies of dystrophin gene mutations in Thai DMD/BMD patients as detected by multiplex PCR. Dis Markers
2008;25(2):115-21.
22. Hassan M J, Mahmood S, Ali G, Bibi N, Waheed I, Rafiq M A, et al. Intragenic deletions in the dystrophin gene in 211 Pakistani Duchenne muscular dystrophy patients. Pediatr Int. 2008; 50:162-6
23. Lo IF, Lai KK, Tong TM, Lam ST. A different spectrum of DMD gene mutations in local Chinese patients with Duchenne/Becker muscular dystrophy. Chin Med J (Engl) 2006 Jul 5;119(13):1079-87.
24. Lai PS, Takeshima Y, Adachi K; Comparative study on deletions of the dystrophin gene in three Asian
populations. J Hum Genet (2002) 47:552-555
25. Khalap NV, Joshi VP, Ladiwalla U, Khadilkar SV, Mahajan SK. A report on higher frequency of DMD gene deletion in the Indian subcontinent. Indian J Hum Genet 1997;3:117-20.
26. Singh V, Sinha S, Mishra S, Chaturvedi LS, Pradhan S, Mittal RD, et al. Proportion and pattern of dystrophin gene deletions in north Indian Duchenne and Becker muscular dystrophy patients. Hum Genet
1997;99:206-8.
27. Dastur RS, Gaitonde PS, Kaldikar SV, Nadkarni JJ. Becker muscular dystrophy in Indian patients: Analysis of dystrophin gene deletion patterns. Neurol India 2008;56:374-77
28. Basak J, Dasgupta UB, Banarjee TK, Senapati AK, Das SK, Mukherjee SC. Analysis of dystrophin gene deletions by multiplex PCR in eastern India. Neurol India 2006;54:310-1.
29. Swaminathan B, Shubha GN, Shubha D, Murthy AR, Kiran Kumar HB, Shylashree S, et al. Duchenne muscular dystrophy: a clinical, histopathological and genetic study at a neurology tertiary care center in
Southern India. Neurol India 2009 Nov-Dec;57(6):734-8
366
www.ijbamr.com
Indian Journal of Basic & Applied Medical Research; December 2012: Issue-5, Vol.-2, P. 357-369
30. Mallikarjuna Rao GN, Hussain T, Geetha-Devi N, Jain S, Chandak GR, Ananda Raj MP. Dystrophin gene deletions in South Indian Duchenne muscular dystrophy patients. Indian J Med Sci 2003;57:1-6.
31. Pizzuti A, Pieretti M, Fenwick RG, Gibbs RA, Caskey CT. A transposon-like element in the deletion-prone region of the dystrophin gene. Genomics 1992;13:594-600
32. Hu XY, Ray PN, Murphy EG, Thompson MW, Worton RG. Duplication mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotype genotype correlation. Am J Hum Genet 1990;46:682-95.
33. Roberts RG, Gardner RJ, Bobrow M. Searching for the 1 in 2,400,000: a review of dystrophin gene point mutations. Hum Mutat 1994;4(1):1-11.
34. Prior TW, Bartolo C, Pearl DK, Papp AC, Snyder PJ, Sedra MS, et al. Spectrum of small mutations in the dystrophin coding region. Am J Hum Genet 1995 Jul;57(1):22-33.
35. Milasin J, Muntoni F, Severini GM, Bartoloni L, Vatta M, Krajinovic M, et al. A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum Mol
Genet 1996;5:73
36. Nishiyama A, Takeshima Y, Zhang Z, Habara Y, Tran TH, Yagi M, et al. Dystrophin nonsense mutations can generate alternative rescue transcripts in lymphocytes. Ann Hum Genet 2008;72:717-24. [Epub 2008 Jul 24].
37. Beggs AH and Kunkel LM. Improved Diagnosis of Duchenne/Becker Muscular Dystrophy. J. Clin. Invet
1990;85:613-619
38. Darras BT, Koenig M, Kunkel LM, Francke U. Direct method for prenatal diagnosis and carrier detection in Duchenne/Becker muscular dystrophy using the entire dystrophin cDNA. Am J Med Genet 1988 Mar;29(3):713-26.
39. Forest SM, GS Cross, A Speer, D Gardner-Medwin, J Burn & KE Davies. Preferential deletions of exons in DMD/BMD. Nature (London) 1987;329:638-640
40. Sinha SP, Mittal RD, Mittal B. Detection of gene deletion in patients of Duchenne muscular dystrophy/Becker muscular dystrophy using polymerase chain reaction. Indian J Med Res 1992; 96:297¬301.
41. Beggs AH, Koenig M, Boyce FM, Kunkel LM; Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 1990;86:45-48
42. Leiden Muscular Dystrophy data pages: http://www.dmd.nl (last updated on Oct 2008); last accessed on:
23 August, 2011.
43. den Dunnen JT, Beggs AH. Multiplex PCR for identifying DMD gene deletions. Curr Protoc Hum Genet 2006; Chapter 9:Unit 9.3
44. Buzin CH, Feng J Yanj, Scaring W, Liu Q, Den Dunne J, Mendell JR, et al. Mutation rates in dystrophin gene: a hotspot of mutations at a CpG dinucleotide. Hum Mutat 2005;25:177-188
45. Feener CA, Boyce FM and Kunkel LM. Rapid Detection of CA Polymorphisms in Cloned DNA: Application to the 5' Region of the Dystrophin Gene. Am. J. Hum. Genet 1991;48:621-627
367
www.ijbamr.com
Indian Journal of Basic & Applied Medical Research; December 2012: Issue-5, Vol.-2, P. 357-369
46. Chaturvedi LS, Srivastava S, Mukherjee M, Mittal RD, Phadke SR, Pradhan S, et al. Carrier detection in non-deletional Duchenne/Becker muscular dystrophy families using polymorphic dinucleotide (CA). Indian
J. Med Res 2001;113:19-25
47. Fujishita S, Shibuya N, Niikawa N, Nagataki S. Gene-deletion and carrier detections, and prenatal diagnosis of Duchenne muscular dystrophy by analysis of the dystrophin gene amplified by polymerase chain reaction. Jinrui Idengaku Zasshi 1991 Dec;36(4):317-24
48. Nakabayashi A, Sueoka K, Tajima H, Sato K, Sakamoto Y, Katou S, et al. Well-devised quantification analysis for duplication mutation of Duchenne muscular dystrophy aimed at preimplantation genetic
diagnosis. J Assist Reprod Genet 2007 Jun;24(6):233-40
49. Stockley TL, Akber S, Bulgin N, Ray PN. Strategy for comprehensive molecular testing for Duchenne and Becker muscular dystrophies. Genet Test 2006;10(4):229-43.
50. Kumari D, Mital A, Gupta M, Goyle S; Human Molecular Genetics Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India; deletion analysis of the DMD gene in DMD patients: use in carrier diagnosis. Neurol India 2003;51:223-6
51. Srivastava NK, Pradhan S, Mittal B, Gowda GA. High resolution NMR based analysis of serum lipids in Duchenne muscular dystrophy patients and its possible diagnostic significance. NMR Biomed 2010
Jan;23(1):13-22
52. Flanigan KM, Dunn DM, von Niederhausern A, Soltanzadeh P, Gappmaier E, Howard MT, et al. Mutational Spectrum of DMD mutations in Dystrophinopathy Patients: Application of modern diagnostic techniques to a large cohort. Hum Mutat 2009;30:1657-1666
53. Wang Q, Li-Ling J, Lin C, Wu Y, Sun K, Ma H, et al. Characteristics of dystrophin gene mutations among Chinese patients as revealed by multiplex ligation-dependent probe amplification. Genet Test Mol Biomarkers 2009 Feb;13(1):23-30.
54. Hegde MR, Chin EL, Mulle JG, Okou DT, Warren ST, Zwick ME. Microarray-based mutation detection in
the dystrophin gene. Hum Mutat Sep 2008;29(9):1091-9.
55. Ashton EJ, yau CS, Deans ZC, Abbs SJ. A Simultaneous mutation scanning for deletions, duplications and point mutations in the DMD gene. Eur. J. Hum. Genet 2008;16:53-61
56. Trimarco A, Torella A, Piluso G, Ventriglia MV, Politano L, Nigro V. Log-PCR: A new tool for Immediate and cost-effective Diagnosis of up to 85% of Dystrophin Gene Mutations. Clinical Chemistry
2008;54(6):973-981
57. Malmgren H, White I, Johansson S, Levkov L, Iwarsson E, Fridström M, Blennow E. PGD for dystrophin gene deletions using fluorescence in situ hybridization. Mol Hum Reprod 2006 May;12(5):353-6. [Epub
2006 Apr 11]
58. Hofstra RM, Mulder IM, Vossen R, de Koning-Gans PA, Kraak M, Ginjaar IB, et al. DGGE-based whole-gene mutation scanning of the dystrophin gene in Duchenne and Becker muscular dystrophy patients. Hum Mutat 2004 Jan;23(1):57-66.
www.ijbamr.com
368
Indian Journal of Basic & Applied Medical Research; December 2012: Issue-5, Vol.-2, P. 357-369
59. Bennett RR, Dunnen J, O'Brien KF, Darras BT, Kunkel LM. Detection of mutations in the dystrophin gene via automated DHPLC screening and direct sequencing. BMC Genet 2001;2:17
60. Tuffery-Giraud S, Chambert S, Demaille J, Claustres M. Genotypic diagnosis of Duchenne and Becker muscular dystrophies. Ann Biol Clin (Paris) 1999;57:417-26.
61. Nixon J, Cockburn D, Hopkin J, Seller A, Huson SM. Service provision of complex mutation analysis: a technical and economic appraisal using dystrophin point mutation analysis as an example. Clin Genet 2002
Jul;62(1):29-38.
62. Kohli S, Saxena R, Thomas E, Singh J, Verma IC. Gene changes in Duchenne muscular dystrophy: Comparison of multiplex PCR and multiplex ligation-dependent probe amplification techniques. Neurol
India 2010;58:852-6
63. Murugan S, Chandramohan A, Lakshmi BR. Use of multiplex ligation-dependent probe amplification (MLPA) for Duchenne muscular dystrophy (DMD) gene mutation analysis. Indian J Med Res 2010
Sep;132:303-11.